126 related articles for article (PubMed ID: 33438217)
1. Silencing of long noncoding RNA MYLK-AS1 suppresses nephroblastoma via down-regulation of CCNE1 through transcription factor TCF7L2.
Zhu S; Zhang J; Gao X; Tang X; Cui Y; Li D; Jia W
J Cell Physiol; 2021 Aug; 236(8):5757-5770. PubMed ID: 33438217
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
Teng F; Zhang JX; Chang QM; Wu XB; Tang WG; Wang JF; Feng JF; Zhang ZP; Hu ZQ
J Exp Clin Cancer Res; 2020 Nov; 39(1):235. PubMed ID: 33168027
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MCF2L-AS1 promotes the aggressiveness of colorectal cancer by sponging miR-874-3p and thereby up-regulating CCNE1.
Huang FK; Zheng CY; Huang LK; Lin CQ; Zhou JF; Wang JX
J Gene Med; 2021 Jan; 23(1):e3285. PubMed ID: 33037865
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MYLK antisense RNA 1 activates cell division cycle 42/Neutal Wiskott-Aldrich syndrome protein pathway via microRNA-101-5p to accelerate epithelial-to-mesenchymal transition of colon cancer cells.
Quan ZH; Xu FP; Huang Z; Chen RH; Xu QW; Lin L
Kaohsiung J Med Sci; 2024 Jan; 40(1):11-22. PubMed ID: 37950620
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation.
Ma J; Han LN; Song JR; Bai XM; Wang JZ; Meng LF; Li J; Zhou W; Feng Y; Feng WR; Ma JJ; Hao JT; Shen ZQ
Cell Oncol (Dordr); 2020 Jun; 43(3):377-394. PubMed ID: 32130660
[TBL] [Abstract][Full Text] [Related]
6. Silencing of long noncoding RNA SRRM2-AS exerts suppressive effects on angiogenesis in nasopharyngeal carcinoma via activating MYLK-mediated cGMP-PKG signaling pathway.
Chen S; Lv L; Zhan Z; Wang X; You Z; Luo X; You H
J Cell Physiol; 2020 Nov; 235(11):7757-7768. PubMed ID: 31742692
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
8. Novel Long Noncoding RNAs,
Qin Y; Tu X; Huang M; Ma C; Huang Q; Huang Q; Shu H; Ou C
DNA Cell Biol; 2023 Aug; 42(8):488-497. PubMed ID: 37527208
[TBL] [Abstract][Full Text] [Related]
9. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Dong H; Jian P; Yu M; Wang L
J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
[TBL] [Abstract][Full Text] [Related]
10. LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca
He H; Wu S; Ai K; Xu R; Zhong Z; Wang Y; Zhang L; Zhao X; Zhu X
Cell Oncol (Dordr); 2021 Feb; 44(1):219-233. PubMed ID: 33001357
[TBL] [Abstract][Full Text] [Related]
11. SOX21-AS1 is associated with clinical stage and regulates cell proliferation in nephroblastoma.
Zhang J; Hou T; Qi X; Wang J; Sun X
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992391
[TBL] [Abstract][Full Text] [Related]
12. Upregulated lncRNA Cyclin-dependent kinase inhibitor 2B antisense RNA 1 induces the proliferation and migration of colorectal cancer by miR-378b/CAPRIN2 axis.
Zheng Y; Zeng J; Xia H; Wang X; Chen H; Huang L; Zeng C
Bioengineered; 2021 Dec; 12(1):5476-5490. PubMed ID: 34511033
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA CDKN2B-AS1 silencing protects against esophageal cancer cell invasion and migration by inactivating the TFAP2A/FSCN1 axis.
Zhu JL; Xue WB; Jiang ZB; Feng W; Liu YC; Nie XY; Jin LY
Kaohsiung J Med Sci; 2022 Dec; 38(12):1144-1154. PubMed ID: 36161699
[TBL] [Abstract][Full Text] [Related]
14. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
Song W; Zhang J; Xia Q; Sun M
Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
[No Abstract] [Full Text] [Related]
15. Long noncoding RNA MYLK-AS1 promotes growth and invasion of hepatocellular carcinoma through the EGFR/HER2-ERK1/2 signaling pathway.
Liu J; Zhao SY; Jiang Q; Qu Y; Huang X; Du J; Sun W; Ye Q
Int J Biol Sci; 2020; 16(11):1989-2000. PubMed ID: 32398965
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MYLK-AS1 acts as an oncogene by epigenetically silencing large tumor suppressor 2 (LATS2) in gastric cancer.
Luo J; Xiang H
Bioengineered; 2021 Dec; 12(1):3101-3112. PubMed ID: 34181498
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin.
Zhang C; Zhu Q; Gu J; Chen S; Li Q; Ying L
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072916
[TBL] [Abstract][Full Text] [Related]
18. EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer.
Liu HT; Liu S; Liu L; Ma RR; Gao P
Cancer Res; 2018 Oct; 78(20):5877-5890. PubMed ID: 30185552
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of long non-coding RNA WT1-AS or silencing of PIK3AP1 are inhibitory to cervical cancer progression.
Tong W; Zhang H
Cell Cycle; 2021 Dec; 20(24):2583-2596. PubMed ID: 34839795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
